Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2001

01-06-2001

Mental adjustment to first recurrence and correlated factors in patients with breast cancer

Authors: Yoshie Okano, Hitoshi Okamura, Toru Watanabe, Masaru Narabayashi, Noriyuki Katsumata, Masashi Ando, Isamu Adachi, Keiko Kazuma, Tatsuo Akechi, Yosuke Uchitomi

Published in: Breast Cancer Research and Treatment | Issue 3/2001

Login to get access
Metadata
Title
Mental adjustment to first recurrence and correlated factors in patients with breast cancer
Authors
Yoshie Okano
Hitoshi Okamura
Toru Watanabe
Masaru Narabayashi
Noriyuki Katsumata
Masashi Ando
Isamu Adachi
Keiko Kazuma
Tatsuo Akechi
Yosuke Uchitomi
Publication date
01-06-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1017942709369

Other articles of this Issue 3/2001

Breast Cancer Research and Treatment 3/2001 Go to the issue

OriginalPaper

Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples

OriginalPaper

Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways

OriginalPaper

Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immunocytochemical assay, and northern blot: a comparison

OriginalPaper

MUC1 expression in primary breast cancer: the effect of tamoxifen treatment

OriginalPaper

Omega-3 fatty acids decrease protein kinase expression in human breast cancer cells

Authors Index

Authors Index
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits